Progress in corneal wound healing.

Corneal wound healing involves multiple cell types and complex biological processes. While general mechanisms of cell migration and matrix remodeling are understood, specific roles of limbal stem cells and myofibroblast activity remain under investigation. Prior research has shown that epithelial healing relies on stem cell activity, while stromal healing involves TGF-β signaling. However, gaps remain in identifying reliable stem cell markers and preventing scarring. This uncertainty has driven recent efforts to refine therapeutic strategies. Researchers have tested gene therapy and microRNA-based approaches to modulate healing. Despite progress, challenges persist in controlling haze formation and targeting drug delivery to specific corneal layers. The field continues to seek better methods to accelerate healing while minimizing complications.

The purpose of the study is to summarize recent findings on corneal wound healing across epithelial, stromal, and endothelial layers. It aims to clarify the roles of limbal stem cells, myofibroblasts, and TGF-β signaling in healing. The study also evaluates emerging therapies like gene therapy and microRNA. Researchers sought to identify gaps in current knowledge, such as the lack of specific stem cell markers and targeted drug delivery systems. They aimed to assess the effectiveness of new treatments for excessive healing and scarring. The study focuses on clinical applications of stem cell transplantation and ROCK inhibitors. It also explores the potential of induced pluripotent stem cells and nanocarriers in wound healing. The goal is to guide future research and clinical practice in corneal repair.

The study reviewed recent literature on corneal wound healing mechanisms and therapies. Researchers analyzed experimental systems involving limbal stem cell cultures and gene therapy models. They examined clinical trials of stem cell transplantation for epithelial regeneration. The methods included evaluating the role of TGF-β in stromal healing and the effects of decorin gene therapy. Researchers also assessed ROCK inhibitors and SMAD7 gene therapy for endothelial healing. The study incorporated data on microRNA and induced pluripotent stem cells for epithelial regeneration. Nanocarriers for drug delivery were reviewed for their potential in corneal treatment. The approach combined experimental findings with clinical outcomes to assess therapeutic advances.

Limbal stem cell-based therapies have advanced in clinical settings for epithelial healing. TGF-β activation leads to myofibroblast formation during stromal healing, and decorin gene therapy has been proposed to control excessive healing. ROCK inhibitors and SMAD7 gene therapy have shown promise in endothelial healing. MicroRNA and induced pluripotent stem cells are being explored for epithelial regeneration. Nanocarriers offer potential for targeted drug delivery to corneal cells. However, reliable stem cell markers remain elusive, and haze prevention is still a challenge. Limited data exist on microRNA regulation in keratocytes and endothelial cells. Targeted delivery systems for drugs and genes to specific corneal layers are still lacking.

The authors highlight the progress in understanding corneal wound healing mechanisms and therapeutic options. They emphasize the clinical adoption of limbal stem cell transplantation for epithelial healing. TGF-β signaling and decorin gene therapy are proposed for stromal healing control. ROCK inhibitors and SMAD7 gene therapy are suggested for endothelial healing. MicroRNA and induced pluripotent stem cells show potential for epithelial regeneration. Nanocarriers may improve drug delivery to corneal cells. However, the authors note the need for better stem cell markers and targeted delivery systems. They propose further research on microRNA regulation and haze prevention to improve clinical outcomes.